Cargando…
Safety and effectiveness of non-vitamin K oral anticoagulants versus warfarin in real-world patients with non-valvular atrial fibrillation: a retrospective analysis of contemporary Japanese administrative claims data
OBJECTIVE: To assess the safety (ie, risk of bleeding) and effectiveness (ie, risk of stroke/systemic embolism (SE)) separately for four non-vitamin K oral anticoagulants (NOACs; apixaban, dabigatran, edoxaban and rivaroxaban) versus warfarin in Japanese patients with non-valvular atrial fibrillatio...
Autores principales: | Kohsaka, Shun, Katada, Jun, Saito, Kumiko, Jenkins, Aaron, Li, Benjamin, Mardekian, Jack, Terayama, Yasuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BMJ Publishing Group
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7174060/ https://www.ncbi.nlm.nih.gov/pubmed/32341789 http://dx.doi.org/10.1136/openhrt-2019-001232 |
Ejemplares similares
-
Risk factors for incident heart failure with preserved or reduced ejection fraction, and valvular heart failure, in a community-based cohort
por: Gong, Fei Fei, et al.
Publicado: (2018) -
Clinical and budget impacts of changes in oral anticoagulation prescribing for atrial fibrillation
por: Orlowski, Andi, et al.
Publicado: (2021) -
Meta-analysis of secure randomised controlled trials of β-blockade to prevent perioperative death in non-cardiac surgery
por: Bouri, Sonia, et al.
Publicado: (2014) -
Prognostic validation of a non-laboratory and a laboratory based cardiovascular disease risk score in multiple regions of the world
por: Joseph, Philip, et al.
Publicado: (2018) -
Effects and costs of real-time cardiac telerehabilitation: randomised controlled non-inferiority trial
por: Maddison, Ralph, et al.
Publicado: (2019)